Group items tagged

The Department of Health and Social Care (DHSC) has redetermined the December 2023 concessionary prices for four medicines following requests made by Community Pharmacy England (CPE) on behalf of community pharmacy owners. For Ezetimibe 10mg tablets (pack size 28), the price has been fixed at £17.78, up from £9.44. Other drugs included in the list are Aripiprazole 5mg (£8.52), Digoxin 125microgram (£3.70) and Digoxin 250micrgram (£3.70) tablets. Contractors would be reimbursed at the new prices only for prescriptions submitted for payment for the dispensing month of December 2023. CPE said they are still working with DHSC to agree price concessions for January. Check the final the December 2023 price concessionary here. Additionally, DHSC on Friday confirmed that there's now sufficient stock of Clarithromycin 125mg/5ml oral suspension to meet normal demand, and the Serious Shortage Protocol (SSP), SSP053 for the antibiotic expires on 12 January 2024.

More than 500,000 women in England have benefitted from cheaper hormone replacement therapy (HRT) since the launch of the HRT prescription prepayment certificates (PPC) on 1 April last year, according to the Department of Health and Social Care (DHSC). HRT is the main treatment for negative menopause symptoms that can impact all areas of a woman's life. Introduced as part of the government's Women's Health Strategy, which made menopause a priority area, the HRT PPC reduced prescription costs to just £19.30 per year, helping patients save hundreds of pounds in prescription charges. The DHSC has confirmed that more than £11 million was saved by women using the PPC in the last nine months. Using the HRT PPC, patients can get a range of HRT items, including patches, tablets, and topical preparations at reduced prices, and they can use it many times as needed throughout the year.

Boots customers were left disappointed as the retail giant closed three more branches, two in Kent and one in Glasgow. On Sunday 21 January, Boots' branches in Cliftonville and Biggin Hill were closed, forcing locals to find an alternative pharmacy, Express.co.uk reported. Cliftonville residents have taken to social media to express their disappointment over the closure of their local pharmacy on Northdown Road. Even though there is another Boots branch in Margate, they said that Cliftonville branch is "much more accessible, with parking available right outside, on the bus route and surrounded by a residential area within easy walking distance." One resident has branded the retailer's decision as "crazy", as per the news portal.

The only way to overcome the challenges facing the medicines supply chain in the UK is through close cooperation - the government, pharmacies, and the industry all working together in tandem - said Andrew Stephenson, Minister for Health and Social Care. The MP for Pendle, Lancashire made the statement while addressing the Healthcare Distribution Association's (HDA) Annual Conference at the Institute of Directors in Pall Mall, London on Thursday (25 January), where over 130 leaders from the pharma industry gathered. As the keynote speaker, Stephenson acknowledged the crucial role wholesalers, manufacturers, and retail pharmacy chains, play in the wellbeing of the nation. He said: "In the first few months that I've been in this job, it's become immediately obvious to me just how important this sector is and just how important the work that all of you do is for our country."

Community Pharmacy England (CPE) has cautioned that patients in the UK will continue to encounter difficulties in accessing medicines unless the government addresses supply problems and resolves the critical financial state of community pharmacies. CPE Chief Executive Janet Morrison and Mike Dent, Director of Pharmacy Funding, on Monday 19 February, gave evidence to the Health and Social Care Select Committee's Pharmacy Inquiry, highlighting the impact of ongoing medicines supply issues on pharmacies and patients. Morrison indicated that a combination of the ongoing "financial squeeze, operational pressures, and medicines supply and pricing issues" has left pharmacy businesses fighting for survival. "As the NHS continues to grapple with wider challenges, this is a battle that patients cannot afford for pharmacies to lose," she said. Morrison warned that if pharmacies continue to close, not only business owners and pharmacy teams will suffer, but patients and local communities will also face the consequences.

NHS England on Monday (19 February) unveiled a new multichannel campaign to inform the public about the additional services offered at their local pharmacy under the recently launched Pharmacy First service. The extended service allows patients to get treatment and medicines from their local pharmacy for seven common conditions, including sinusitis, sore throat, earache, infected insect bite, impetigo, shingles, and uncomplicated urinary tract infections in women, without needing to see a GP. As part of its 'Help Us, Help You' campaign, NHS England has started running adverts across on-demand TV services, radio, bus stops and billboards as well as social media, encouraging people to use their high street pharmacies for treatment of these common illnesses.

The Royal Pharmaceutical Society (RPS) and the Pharmacists' Defence Association (PDA) have responded to the Department of Health and Social Care (DHSC) consultation on pharmacy supervision, which was launched in early December last year. The DSHC set out proposals to amend the Medicines Act 1968 and The Human Medicines Regulations 2012 to allow registered pharmacy technicians to work without direct supervision, which in turn will help free up pharmacists to provide more clinical care and reduce GP appointments. While the RPS supported the legislative change, it highlighted a range of topics that should be considered and clarified in regulations and guidance. According to RPS, the new concept of 'authorisation', including around documentation, accountability, and the role of superintendent pharmacist and responsible pharmacist, needs clarification.

The British Generic Manufacturers Association (BGMA) on Monday alerted the Health and Social Care Committee that medicines shortages have increased and are "around double what they were a year ago." BGMA chief executive Mark Samuels told the committee that they have been highlighting the medicine shortage risk to ministers since July 2021 and the association is "very concerned" about the current situation. "We've been monitoring it for several years now, and as you saw in the written evidence, shortages have increased. They're around double what they were a year ago. We have them at 101 shortages in February this year," said Samuels. Dr Rick Greville, director of distribution and supply at the Association of the British Pharmaceutical Industry (ABPI), highlighted that the problem of drug shortages in the UK is a "long-standing issue" and the scarcity of certain medications "continues to be challenging".

In a decisive move highlighting the financial strain faced by community pharmacies, the National Pharmacy Association (NPA) submitted a £108 million invoice to the Department of Health and Social Care (DHSC) today (16 May). According to the NPA, this substantial sum represents the amount that pharmacies in England personally covered for the dispensing of NHS medicines last month, as a result of inadequate funding. "The £108m figure is an average monthly figure based on the loss to pharmacy incomes over the past decade," it said. The association believes that mass closures can be prevented only when the government stops expecting pharmacies to subsidise the cost of delivering NHS care. NPA chief executive Paul Rees, said: "The soaring costs of dispensing medicine coupled with declining real terms funding has led to community pharmacies in England having to subsidise the dispensing of drugs to the tune of £108m a month.

"Record long NHS waits are forcing huge numbers of people out of work, including doctors and nurses," said Wes Streeting MP, Labour's Shadow Health and Social Care Secretary as Labour announced a new partnership with Nuffield Health today to tackle joint pain issues among NHS staff and reducing waiting lists. Musculoskeletal problems, including back, knee, hip, and neck pain, are the second leading cause of NHS staff absences, surpassed only by mental health issues. In December 2023 alone, NHS workers missed a record 198,000 days due to these issues, marking a 13 per cent increase from the 174,000 days recorded in December 2019. Nurses and health visitors accounted for 52,000 of these days, up from 47,000 pre-pandemic, while doctors took 3,500 days off, a 9 per cent increase from 2019. The partnership with Nuffield Health will provide up to 4,000 extra places for NHS staff in Nuffield Health's Joint Pain Programme at no cost.

The World Health Organization (WHO) reiterated its concerns about tobacco companies' continued targeting of young people through various channels such as social media, sports, and music festivals, as well as the introduction of flavored products. In a joint report with industry watchdog STOP released on Thursday, the WHO accused these companies of attempting to ensnare a new generation in nicotine addiction. While facing stricter regulations on traditional cigarettes, major tobacco firms and newcomers have turned to alternatives like vapes, arguing they are intended for adult smokers. However, the WHO and STOP highlighted in their report that these products often appeal to youth, with their attractive designs and fruity flavors making them more appealing to children than to adults in many countries.

Feeling stressed and finding it difficult to fit everything into the day? Perhaps it's time to join the mindfulness revolution.

Acne, pimples, and zits make us look unappealing and we tend to rob ourselves from social activities. #pimples #acne #acnetreatment https://youtu.be/_Dhid4cVreQ

Arthrella is a rich combination of joint support phytochemicals. Arthrella combines the extracts of 4 herbs which offer support to the bones and the joints and help regulate healthy active joints and muscles. Arthrella helps in promoting normal structure and functioning of musculoskeletal system Social Media Site https://www.youtube.com/user/CharakPharma https://www.facebook.com/CharakPharma https://twitter.com/charak_pharma https://plus.google.com/+charakpharma https://www.linkedin.com/company/charak-pharma-pvt.-ltd. https://www.pinterest.com/OTCSupermarket/charak-pharma/ https://plus.google.com/u/0/communities/112690639266834894016 CONTACT US Charak Pharma (USA) inc 303-5th Avenue, Suite # 1007 New York, NY 10016 United States Website- http://www.charakusa.com/ Email : enquiry@charakusa.com info@charakusa.com 91 22 33016734 Google My Business Location- http://listings.findthecompany.com/l/474216049/Charak-Pharma-Usa-Inc-in-New-York-NY Buy Innoveda Arthrella Online - Shop, Cart & checkout Page Url Shop - http://www.charakusa.com/shop/ Add to Card - http://www.charakusa.com/cart/ Proceed to Checkout- http://www.charakusa.com/checkout/

Social Stress, Anxiety disorder is the issues that today's youth are suffering the most. According to the statics, 2% to 3% of Americans suffer a panic attacks, stress, anxiety, depression. Take care of your treasure.

As America reopens and adjusts to the new normal, medical practices have a responsibility to fulfill. They have to implement the safety protocols within their clinics and continue to save lives. We have brought forward five tips to align your practice with the social distancing protocols; to keep it as a place where people heal rather than the opposite.

The August 2020 edition of the Journal of Vascular Surgery published an article, "Prevalence of Unprofessional Social Media Content Among Young Vascular Surgeons," that incited an uproar among young doctors. It compelled us to stand in support of these young professionals, the lifeline of American medicine.

The Royal Pharmaceutical Society (RPS) and the charity Marie Curie have developed a consultation on 'professional standards for palliative and end of life care for community pharmacy'. The consultation will be open for four weeks for community pharmacists, organisations with a role in community pharmacy or palliative/end of life care, or patients or carers with first-hand experience of palliative and end of life care to share their views until 1st December 2022. Through this consultation, Society aims to that ensure the standards are clear, relevant, current, and fit for purpose from the perspective of the community pharmacy team, the wider health team and patients/carers. "The final standards will be published in 2023 and will help community pharmacies across the UK to self-assess and continuously improve their palliative, end of life and bereavement care," said RPS.

IAM Healthcare and pharmacy labour activists have initiated a new worker empowerment project to help pharmacies unionise over unsafe staffing levels and increasing workloads. The campaign is coined "The Pharmacy Guild" to establish higher standards of practice in pharmacies to protect patients. The union issued a mission statement on Wednesday (8 November) highlighting three major demands and goals. They demanded that "staffing and workload standards should be set up to ensure safe patient care." There should be "representation and collective bargaining for pharmacy professionals in workplaces across the country."

The Department of Health (DoH) has launched a new programme to provide pharmacy undergraduate students in Northern Ireland with clinical placements across hospital, community and general practice settings. It has commissioned the Northern Ireland Centre for Pharmacy Learning and Development (NICPLD) at Queen's University Belfast (QUB) to deliver the new Experiential Learning (EL) programme. NICPLD will work with QUB, Ulster University (UU) and local employers to co-ordinate the work placements, the department said. Students across years 2- 4 of the Masters of Pharmacy course will be given up to 12 weeks of Experiential Learning with multisector placements in hospital (6 weeks), community pharmacy (3 weeks) and general practice (3 weeks).